California

California Law360 provides breaking news and analysis on legal and regulatory issues in California. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.



Sign up for a 7-day FREE trial today!



Latest News in California

  • September 21, 2023

    Designer Alleges Racism, Threats Backstage On Lizzo Tour

    A fashion designer who created custom pieces for Lizzo's dancers on tour claims she was threatened, denied medical care and subjected to racial and sexual harassment while on the job, according to a new lawsuit lodged Thursday against the Grammy-winning pop star and her touring company.

  • September 21, 2023

    Cities Score Class Cert. In Rate-Rigging Suit Against Banks

    A New York federal judge on Thursday granted class certification to a group of American cities that are accusing eight large banks of inflating interest rates on debt securities known as variable rate demand obligations, overruling the banks' arguments that the cities couldn't show common issues prevailed among the different plaintiffs.

  • September 21, 2023

    Calif. Sues 'Predatory' Clinics Over 'Abortion Pill Reversal'

    California Attorney General Rob Bonta on Thursday accused several "crisis pregnancy centers" of falsely advertising an unproven and experimental procedure that supposedly reverses a medication abortion, claiming the procedure is risky and slamming the clinics for being "predatory."

  • September 21, 2023

    Google Judge Questions Need For Health Tracking Injunction

    A California federal judge on Thursday appeared disinclined to block Google LLC from tracking user analytics from health care providers' websites while users litigate their allegations the tech giant is unlawfully gathering patient health information, saying the plaintiffs haven't shown that Google is misusing the information.

  • September 21, 2023

    Gilead Sciences Gets Initial OK On $247M HIV Antitrust Deal

    A California federal judge on Thursday granted preliminary approval to Gilead's deal to pay the direct purchasers of its HIV medications $246.8 million to end claims the pharmaceutical company cut a deal with Teva to delay generic versions, saying considering the litigation risks, "the settlement is a reasonable one."

See more California news

California

Areas of Coverage

  • AGENCIES
  • California Attorney General’s Office
  • California Department of Business Oversight
  • California Department of Insurance
  • California Department of Transportation
  • California Environmental Protection Agency
  • California Public Utilities Commission
  • Department of Consumer Affairs
  • State Controller’s Office
  • ENFORCEMENT
  • Investigations and enforcement actions by state and federal prosecutors
  • Food safety actions
  • LITIGATION
  • Antitrust litigation
  • Class actions
  • Environmental suits
  • Labor and employment issues
  • Intellectual property cases
  • Product liability and consumer protection disputes
  • Securities disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures involving California companies
  • Real estate deals
  • PROFILES
  • Nominations, appointments, and elections of judges and agency officials in California
  • Personnel moves
  • Profiles of California judges, litigators, and firms

Readership

  • Lawyers at top law firms practicing in California
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys working with California-based companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!